ELV Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
50.5B
+0.6%
50.2B
+0.9%
49.7B
-1.9%
50.7B
+1.9%
49.8B
Cost of Revenue
37.0B
+4.0%
35.6B
-6.4%
38.1B
-0.2%
38.1B
+3.9%
36.7B
Gross Profit
13.4B
-7.7%
14.6B
+24.7%
11.7B
-7.1%
12.6B
-3.8%
13.1B
Operating Expenses
48.2B
+1.4%
47.5B
-3.3%
49.2B
+0.4%
49.0B
+3.8%
47.1B
R&D
SG&A
5.5B
-12.4%
6.3B
+16.9%
5.4B
+2.7%
5.3B
+5.5%
5.0B
Operating Income
2.3B
-13.5%
2.7B
+358.0%
581.0M
-66.9%
1.8B
-33.3%
2.6B
EBITDA
2.7B
-11.5%
3.0B
+205.5%
987.0M
-54.0%
2.1B
-28.8%
3.0B
Net Income
1.5B
-17.4%
1.8B
+222.3%
546.0M
-54.0%
1.2B
-31.9%
1.7B
EPS (Basic)
$6.74
-16.1%
$8.03
+214.9%
$2.55
-52.1%
$5.32
-31.3%
$7.74
EPS (Diluted)
$6.71
-16.1%
$8.00
+215.0%
$2.54
-52.3%
$5.32
-31.1%
$7.72
Shares (Diluted)
217.9M
-1.1%
220.4M
-1.9%
224.6M
+0.4%
223.7M
-0.9%
225.8M
Elevance Health (ELV) — Financials